
    
      The aim of the present study was to compare ocular tolerance and safety after repeated
      instillations of T1225 1% and 1.5% eye drops and vehicle and to assess the residual
      azithromycin concentrations in tear, ocular conjunctiva and plasma samples, approximately 12
      hours after the last Investigational Medicinal Product instillation.
    
  